Lithuanian Biotech Pioneer ‘Nando’ Embarks on Global Expansion With New Management Team and Innovative Production Line

KAUNAS, LITHUANIA, May 7, 2024 – (ACN Newswire) – In a strategic enhancement of its management team, “Nando” welcomes four seasoned professionals, each bringing a wealth of experience from reputable organizations. Gytis Kubilius, with a solid background in management at “SEB” and “Citadele” banks; Mindaugas Navickas, previously International Sales Manager at “Teltonika Networks”; ArÅ«nas Jusas, former General Manager at “Timac AGRO”; and GiedrÄ— MockienÄ—, who served as HR Manager at UAB “Yara”, are now integral parts of “Nando’s” leadership, aiming to spearhead ambitious development projects.

To cater to the surging demand for microbiological alternatives to mineral fertilizers and plant protection products, “Nando” has invested about €3 million in a unique biotechnology line. This investment boosts production volume, enhances productivity, and ensures competitive pricing to meet the escalating market demand. With a technology that is currently patent-pending, “Nando” exports to over 20 countries, including Great Britain, Ukraine, Estonia, Kazakhstan, Latvia, Poland, Romania and beyond.

Justinas Taruška, CEO of “Nando”, stated, “Our main goal is to feature a highly automated biotechnological production line. This will not only elevate the agro-biotechnology sector’s value in Lithuania but also accelerate sustainable and economically viable agricultural technologies across Europe and other continents.” The new production line is renowned for its unique microorganism purification technology, a rarity in the entire Baltic region. It promises an efficient production of stable, high-yield microbiological products in powder form, a technology with limited competition.

The inclusion of new management members, with their extensive international experience, underscores “Nando’s” commitment to employee development and its focus on penetrating foreign markets, including Europe, North and South America, Asian and Africa countries. This strategic move coincides with the launch of the new production line for microbiological products.

Founded in 2007, “Nando” stands at the forefront of the biotech industry, developing and manufacturing microbiological products and chemical additives for agriculture. With one of Northern Europe’s leading R&D centers and partnerships with global research institutions, “Nando” has introduced over 50 innovative products, vital to the agro, livestock. Currently, the company is intensifying its export activities, with operations spanning over 20 countries in Europe, North and South America, Asian and Africa. The “Nando Group” proudly employs more than 50 professionals dedicated to advancing global biotechnology solutions.

Contact Information:
Milda Gauliene
Marketing specialist
milda@nando.lt
+37066475297

SOURCE: Nando

View the original press release on newswire.com.

HKTDC launches International Healthcare Week

Asia Summit on Global Health features Nobel laureate Prof Roger Kornberg speaking on cutting-edge biotech advances.
Hong Kong International Medical and Healthcare Fair attracts some 300 exhibitors and diverse country and regional pavilions from around the world.

HONG KONG, May 7, 2024 – (ACN Newswire) – The third International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC), takes place from 15 to 31 May. The week’s flagship event, the Asia Summit on Global Health (ASGH), co-organised by the Hong Kong SAR Government (HKSAR) and HKTDC, will be held at the Hong Kong Convention and Exhibition Centre (HKCEC) on 16 and 17 May. Another flagship event, the Hong Kong International Medical and Healthcare Fair (Medical Fair), will run concurrently from 16 to 18 May, highlighting Hong Kong’s strengths in healthcare.

Margaret Fong, Executive Director of the HKTDC, said: “Hong Kong’s healthcare system is world-renowned. The 2023 Policy Address announced various measures to turn Hong Kong into a health innovation hub and develop its silver economy. We have been keen to promote medical technology and devices, and this year, the concurrent ASGH and Medical Fair once again bring together local and international healthcare experts to discuss the industry’s hot topics, including AI, healthy ageing and Chinese medicine. A Nobel laureate in Chemistry will also highlight the latest innovative biotech solutions. The two events will showcase a series of robotics technologies as well as the latest healthcare products and solutions for the silver economy. They offer exhibitors, investors and buyers a platform to build connections and foster cross-sector collaboration. This will play an important role in transforming Hong Kong into a health and medical innovation hub.”

Aside from ASGH and the Medical Fair, IHW features the Hospital Authority Convention, among many other industry events.

Industry leaders explore healthcare opportunities

Themed Innovation . Inclusion . Impact, the fourth ASGH brings together medical and healthcare government representatives and organisations, internationally renowned scientists and medical experts, investors and business leaders from around the world. In addition to public health, medtech, international trade cooperation and investment, they will analyse the industry’s outlook and business opportunities.

Dr Peter K N Lam, Chairman of the HKTDC, presents welcome remarks, John Lee, Chief Executive of the HKSAR, delivers opening remarks and Prof Cao Xuetao, Vice-Minister of the National Health Commission of the People’s Republic of China, gives special remarks on the opening day of ASGH.

The ASGH Plenary Sessions explore opportunities in the healthcare industry and promote cooperation across the medical and healthcare fields. For the first plenary, Prof Lo Chung-mau, Secretary for Health of the HKSAR, shares his vision and addresses the preparatory work for the establishment of the Hong Kong Centre for Medical Products Regulation and the progress made in promoting Hong Kong as a health innovation hub.

Other speakers include Prof Lau Chak-sing, Dean of Medicine of The University of Hong Kong; Prof Lo Yuk Lam, President of the HK Bio-Med Innotech Association; Dr Sun Zhigang, Senior Vice President of Luye Pharma Group Ltd, and more. They will discuss the drug approval systems in Mainland China and overseas, exploring how they can benefit the healthcare ecosystem.

At the second plenary, Prof Roger Kornberg, Nobel Laureate in Chemistry in 2006 highlights biotech advances and engages in dialogue on emerging technologies and healthcare innovation trends with Victor L L Chu, Chairman and CEO of First Eastern Investment Group, and Leslie Lu, Executive Director and CEO of EC Healthcare, among others.

During the Dialogue with Global Pioneer in Health session, Prof Michael Hanna, Director of UCL Queen Square Institute of Neurology, sheds light on the latest trends and findings in neurology. ASGH also spotlights China’s healthcare ecosystem, highlighting the latest developments in healthcare in the vast market, key investment areas and major trends shaping the country’s healthcare sector.

For the plenary session on the second day of the Summit, The Hon Bernard Charnwut Chan, Chairman and President of Asia Financial Holdings Limited; Dr Sangtae Kim, Chief Technology Officer of Bertis Bioscience; Yasushi Okada, Representative Corporate Officer and COO of Eisai Co., Ltd.; Dr Sarah Salvilla, Group Chief Health Officer of FWD Group, and more will explore the current landscape of medical innovation in Asia, encompassing trends, investments and collaboration.

Thematic sessions discuss precision medicine, innovative drugs, neuroscience, healthcare investment prospects, opportunities in healthcare insurance and more.

InnoHealth Showcase and deal-making connect start-ups with investors

ASGH deal-making connects investors and project owners from across the globe in-person and online to discuss collaboration opportunities.

Participating investors represent a diverse range of backgrounds, including angel investors, venture capitalists and corporate venture capital, private equity firms, family offices and more. Investment interests span pharmaceuticals, medical devices and diagnostics, AI and digital health, and community health and wellness.

The exhibition area, which includes the InnoHealth Showcase, features healthcare investment projects and cutting-edge technologies from over 150 companies at the forefront of healthcare innovation. Among them, over 70 healthcare start-ups and projects, many of which are award-winning, are led by six local universities and Cyberport. Besides the Innovation and Technology Commission, Investment NSW and the Sichuan Provincial Administration of Traditional Chinese Medicine bring healthcare start-ups and institutions to Hong Kong for the first time to help them connect with potential partners and investors.

Medical Fair facilitates industry collaboration

The Medical Fair, organised by the HKTDC and co-organised by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA), serves as the ideal platform for industry professionals, including R&D institutions, manufacturers, public healthcare institutions, hospitals, clinics, wholesalers and medical healthcare professionals, from around the world to establish business connections and gather insights on the latest developments in the medical field.

Themed Innovations Boosting Smart Health Experience, this year’s Medical Fair welcomes some 300 exhibitors from eight countries and regions and features a wide range of exhibition zones, including Biotechnology, Hospital Equipment, Rehabilitation and Elderly Care Products, Startup, and the HKMHDIA Pavilion zones.

Exhibitors showcase medical technology solutions that utilise AI and robotics technology. In the Laboratory Equipment and Manufacturing Solutions zone, exhibitors feature cold-chain logistics solutions that incorporate innovative, efficient data recording devices. These solutions enable real-time monitoring of vaccine and medicine delivery status, ensuring compliance with regulatory requirements, while optimising cost control.

The Medical Fair features a strong line-up of leading research and academic institutions, including six local universities. The Hong Kong Science and Technology Parks Corporation (HKSTP) pavilion showcases the latest advancements in medical equipment, testing and analysis solutions and telemedicine technologies of over 30 companies. Additionally, with the support of the HKMHDIA, 20 companies exhibit their latest medical imaging equipment and health monitoring products.

The debut Hungary, Chongqing (China) and Jilin (China) pavilions, alongside the returning Canada pavilion, showcase a range of medical instruments, reagent consumables, diagnostic technologies and antibacterial coatings applicable to various fields, such as analytical testing science, clinical diagnosis, food and pharmaceutical safety and life sciences. Traditional Chinese medicine and supplements are also featured.

One of the many Medical Fair events, the HKMHDIA Medical Fair Forum discusses Hong Kong’s smart healthcare innovation and transformation. Other seminars explore the latest trends in smart ageing technology, IoT applications in digital healthcare, the application of mixed reality and AI for medical imaging, and more.

Using the HKTDC EXHIBITION+ hybrid model, the physical fair from 16 to 18 May is complemented by the Click2Match smart business matching platform, via which buyers can extend their sourcing journey from 9 to 25 May.

Asia Summit on Global Health
Date	16-17 May 2024 (Thursday to Friday)
Time	The Opening Session will begin at 10:00 am
Venue	Hong Kong Convention and Exhibition Centre (HKCEC) Hall 3FG
Hong Kong International Medical and Healthcare Fair
Date	16-18 May 2024 (Thursday to Saturday)
Venue	Hong Kong Convention and Exhibition Centre (HKCEC) Hall 3DE

Photo download: https://bit.ly/4b8utEm

Prof Roger Kornberg, 2006 Nobel laureate in Chemistry is one of the featured keynote speakers at the Asia Summit on Global Health.

Prof Michael Hanna, Director of UCL Queen Square Institute of Neurology, shares the latest trends and findings in neurology in the Dialogue with Global Pioneer in Health session at the Asia Summit on Global Health.

ASGH deal-making facilitates connections between project owners and investors in-person and online.

The HKSTP pavilion showcases medical testing and analysis technologies at the Hong Kong International Medical and Healthcare Fair.

With the support of the HKMHDIA, 20 companies exhibit the latest medical imaging equipment and health monitoring products.

This year’s Medical Fair features eight key product zones, including Biotechnology, Hospital Equipment and Rehabilitation and Elderly Care.

The Asia Summit on Global Health was held successfully last year.

The Medical Fair attracts global buyers seeking the latest advances in medical equipment, technological solutions and healthcare products.

Websites

International Healthcare Week: https://internationalhealthcareweek.hktdc.com/en

Asia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/en
Programme: https://www.asiasummitglobalhealth.com/conference/asgh/en/programme
Speakers: https://www.asiasummitglobalhealth.com/conference/asgh/en/speaker

Hong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/en
List of products: https://www.hktdc.com/event/hkmedicalfair/en/product
Activity schedule: https://www.hktdc.com/event/hkmedicalfair/en/intelligence-hub

Members of the media interested in interviewing ASGH speakers can send an email to hktdc@hkstrategies.com on or before 10 May, 2024.

Media enquiries

For enquiries, please contact Hill & Knowlton:

Joyce Kwong	Tel: (852) 2894 6321	Email: joyce.kwong@hillandknowlton.com
Lynn Zhang	Tel: (852) 2894 6321	Email: lynn.zhang@hillandknowlton.com

HKTDC’s Communications & Public Affairs Department:

Asia Summit on Global Health

Clayton Lau

Tel: (852) 2584 4472

Email:clayton.y.lauw@hktdc.org

Hong Kong International Medical and Healthcare Fair

Jane Cheung

Tel: (852) 2584 4137

Email:jane.mh.cheung@hktdc.org

Media Room: http://mediaroom.hktdc.com

About HKTDC

The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong’s trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn

Mastering the AI Revolution: MetaHomes Ushers Intelligent AI Features into Real Estate Amidst Dubai’s Booming Market

DUBAI, May 7, 2024 – (ACN Newswire) – The global real estate landscape is on the cusp of revolution, driven by artificial intelligence (AI). While headlines often focus on booming markets like Dubai (and for good reason), a quieter storm is brewing, poised to transform how we buy, sell, rent and manage property, ushering in an era of unprecedented efficiency and personalization.

MetaHomes

Mastering the AI Revolution: MetaHomes Ushers Intelligent AI Features into Real Estate Amidst Dubai’s Booming Market

It is no doubt that Dubai’s real estate market has become a global phenomenon. Visionary infrastructure development projects like Palm Jumeirah, the Dubai Museum of the Future, Palm Jebel Ali and the iconic Burj Khalifa stand as testaments to the city’s commitment to progress. This, coupled with a robust economy and a safe bubble index (according to Statista), has attracted investors, fueling a vibrant real estate ecosystem.

The city’s relentless growth, with a staggering 19.3% property value increase in Q1 2024 compared to the same period last year, presents a unique opportunity for innovation and sustained growth. Developers are responding by launching new projects at an unprecedented pace, with a new one hitting the market every 17 hours according to Allsop & Allsop. As the city continues to solidify its position as a global hub for real estate expansion, investment and innovation, the spotlight shines brightly on MetaHomes, a prominent online real estate marketplace that offers a comprehensive suite of services for all, including real estate investors, developers, and agents.

The platform uses advanced algorithms and machine learning to analyze millions of data points from various sources, such as property listings, images, videos, and customer feedback. Based on these analyses, MetaHomes provides valuable insights and recommendations that help customers make informed decisions, optimize their strategies, and maximize returns. Luxury apartments and villas for rent, including furnished apartments, and commercial properties like retail and offices for rent are some of the properties available on MetaHomes.

In a statement, MetaHomes’ CEO, Jerry Wu, said: “We believe that AI is the future and we are committed to providing our clients with the best-in-class technology that can help them achieve their goals. Our platform is designed to be user-friendly, flexible, and scalable, so that it can adapt to any market conditions and customer needs. We are confident that our platform will revolutionize the real estate industry and set new standards for excellence.”

The global real estate market presents a complex picture, with investors hungry for data insights. Navigating this dynamic terrain requires the need for innovative tools such as virtual reality facilities. With a rising tide of a tech-driven future championed by MetaHomes, the stage is set for an era of unprecedented growth and innovation in the real estate market.

Zohaib Pervaiz
zohaib@metahomes.net

Contact Information
Zohaib Pervaiz
PR Specialist
zohaib@metahomes.net
00971529326142

SOURCE: MetaHomes (Metaworld Technology FZ LLC)

View the original press release on newswire.com.

Alpha Trends Introduces Solution for CFD Trading, Combining AI and Expert Financial Guidance

LONDON, May 7, 2024 – (ACN Newswire) – Alpha Trends has launched its solution for CFD Trading, which leverages a unique combination of advanced AI technology with expert human guidance. This synergistic approach allows Alpha Trends to deliver precise, informed investment strategies that optimize portfolio performance while effectively managing risk, highlighting the blend of innovative technology and deep financial expertise.

Personalized Financial Guidance by Veteran Market Experts

At Alpha Trends, we recognize that entering or enhancing one’s presence in CFD trading requires sophisticated, expert guidance. Our team, comprised of financial experts with decades of capital market experience, provides bespoke advisory that simplifies complex trading scenarios, enabling clients to navigate the markets confidently and profitably.

“Our mission is to demystify the complexities of CFD trading for our clients, furnishing them with personalized tools and knowledge essential for success,” stated Andrew Sage, CEO of Alpha Trends. “We cater specifically to the needs of high-net-worth individuals who seek both security and profitability in their investment endeavors.”

Advanced AI Trading Tools on an Award-Winning Platform

The backbone of Alpha Trends is its state-of-the-art trading platform, enhanced by AI trading tools that perform real-time market analysis. This technology facilitates strategic trading decisions, ensuring that our clients are positioned to capitalize on market movements effectively and securely.

“Our platform is celebrated for its user-friendly interface and robust functionality, crucial for navigating today’s fast-paced financial markets,” added Edward Collins, Chief Investment Strategist at Alpha Trends. “We integrate artificial intelligence to provide a predictive edge in market trends, delivering a competitive advantage to our clients.”

For detailed information regarding the different trading account options available, please visit our website at https://www.alphatrends.io/account-types. At Alpha Trends, we offer a variety of account types to suit the diverse needs and strategies of our investors, ensuring a tailored approach to CFD trading that aligns with your financial goals.

Optimal Investment Opportunities in 2024

Looking ahead to 2024, the investment landscape offers significant opportunities, particularly in areas like cryptocurrencies and top-performing stocks. With the anticipated Bitcoin halving in 2024, cryptocurrency investments are particularly promising. Historical trends around such events have shown considerable price surges in Bitcoin, hinting at lucrative potential for informed investors.

Beyond crypto, other areas poised for strong performance include Gold, which continues to be a reliable hedge against inflation and economic uncertainty. The Dow Jones Industrial Average has reached unprecedented highs, reflecting robust fundamentals in ‘blue-chip’ stocks. Companies like Nvidia have shown stellar performance thanks to increasing demand in AI technologies, while Rolls-Royce has emerged as a top performer in the FTSE 100, benefiting from global macroeconomic shifts.

“These selected investment avenues exemplify the type of opportunities Alpha Trends brings to our clients’ portfolios,” explained Doe. “Our expert advisors are adept at identifying and leveraging such trends, ensuring that our clients can achieve their financial goals with greater assurance and efficacy.”

About Alpha Trends

Alpha Trends is dedicated to serving high-net-worth individuals through a platform that combines in-depth financial expertise with sophisticated technological tools. We are committed to delivering a trading experience that is safe, profitable, and tailored to the unique needs of each client. At Alpha Trends, your financial legacy is our priority.

Explore how Alpha Trends can redefine users’ investment strategy and help them maximize their financial potential. Visit their website at https://www.alphatrends.io to learn more or to arrange a consultation with one of our expert financial advisors.

For media inquiries
Brand: Alpha Trends
Contact: Lea Kenworthy, Head of Compliance
Website: https://www.alphatrends.io

SOURCE: Alpha Trends

Armor Unveils a Disruptive Approach to Managed Detection and Response

DALLAS, TX, May 6, 2024 – (ACN Newswire) – Armor, a leading provider of cybersecurity and compliance solutions, is thrilled to announce the launch of its latest offering Armor Managed Detection and Response (MDR), ushering in a different era for MDR through adaptive threat management and defense.

Logo for Armor

Enterprises are challenged by an array of evolving cyber threats, and yet conventional MDR strategies fixate on detection and response, without an integrated risk management approach. Armor MDR addresses this critical gap by integrating with industry-leading security platforms for unparalleled threat context – enabling high confidence triage, response and defense optimization.

Our partnership with Microsoft in particular, supercharges solutions like Microsoft Defender XDR and Microsoft Sentinel to fully harness their power for adaptive threat prevention, detection and response.

“In view of the modern sophistication of cyber threats, and current state of cybersecurity, adaptivity isn’t just an advantage; it’s the very foundation of digital defense,” said Dennis Chung, Chief Security Officer, Microsoft. “Novel approaches like Armor MDR empowers enterprises to out-maneuver advanced threats through proactive and adaptable defenses.”

Chris Drake, Founder and CEO of Armor, said, “Attempting to tackle emerging cybersecurity threats with traditional Threat Detection, Investigation and Response (TDIR) is a clumsy approach that likens playing whack-a-mole. To truly raise defensibility requires strategic and continuous improvements at the source – that’s what Armor has launched.”

The Armor MDR service is grounded in these distinctive core principles:

Contextual Threat Prioritization and Response: By developing a unique enterprise risk profile per customer, this rich context empowers Armor MDR to determine the pertinence and impact of potential security threats more effectively and swiftly neutralize potential threats before they escalate.

Analytics-Powered Security Strategies: Outcome-driven metrics are used to inform and uncover security improvements. By harnessing the power of artificial intelligence and machine learning, Armor’s MDR service captures opportunities to accelerate incident response, leverage automation to enhance the TDIR process, and proactively improve security configurations.

Continuously Raising Defensibility: The insights from security incident triage and remediation are integrated into a feedback loop to update relevant security configurations, thereby significantly improving enterprise risk resiliency and threat prevention.

The service is now available to organizations seeking to fortify their cyber defenses against the unyielding tide of cyber threats, and industry partners looking to provide enhanced security outcomes for their customers. For more information about Armor and the Armor MDR service, visit www.armor.com/solutions/armor-mdr.

ABOUT ARMOR

Armor, a global cybersecurity leader, provides comprehensive managed detection and response (MDR) and compliant cloud solutions. By combining advanced technology with expert services, Armor protects businesses from cyber threats, mitigates their risk, and ensures regulatory compliance. Dedicated to innovation and excellence, Armor is trusted by thousands of customers worldwide. The company is headquartered in Dallas, Texas, and has offices in the United States, United Kingdom, and Singapore.

For more information, visit www.armor.com.

Contact Information
Armor PR
Armor Corporate Communications
press@armor.com
877 262 3473

Eloise Garrett
Director, The Right Agency
eloise@rightagency.co.uk
+44 7976048542

SOURCE: Armor

View the original press release on newswire.com.

Yee Hop Holdings’ (1662.HK) Subsidiary APEL Triumphs with Three Medals at the International Exhibition of Inventions Geneva

HONG KONG, May 6, 2024 – (ACN Newswire) – Absolute Pure EnviroSci Limited (“APEL”), under the strong support of its parent company, the listed company Yee Hop Holdings Limited (stock code: 1662.HK), has achieved remarkable development. The company’s team has demonstrated outstanding innovation and pioneering research results, quickly gaining international recognition. APEL performed excellently at the 49th International Exhibition of Inventions Geneva, with three scientific research entries respectively winning two gold and one bronze medals, achieving a 100% success rate. This exhibition is one of the largest international exhibitions of inventions, providing inventors and researchers with a unique opportunity to showcase research results and new products. The 49th International Exhibition of Inventions Geneva was held in April in Geneva, Switzerland, featuring over 1,000 inventions from 38 countries and regions. The awards were selected by an international panel of experts.

Boasting Remarkable Achievements and Demonstrating Leadership in Innovative Technology

APEL, with its outstanding technological innovation capabilities, has proposed innovative solutions to urgent global problems, making significant contributions to Hong Kong, Mainland China, and even the world. APEL garnered several awards at the 49th International Exhibition of Inventions Geneva, including:

Gold Medal – Low-carbon Multi-purpose Silica Encapsulating Technology

This technology brings revolutionary changes to human society by using silica capsule to alter the size and structure of products, greatly reducing waste and carbon emissions throughout the product lifecycle, thereby providing a sustainable and low-carbon alternative for human life. This technology can encapsulate concentrated ingredients and enable smart release with water, thereby enhancing the product’s lifespan and effectiveness. Products compressed into silica capsules also correspondingly reduce their volume and weight by over 80%, significantly reducing manufacturing, transportation, packaging, and storage requirements, and lowering carbon emissions by over 90%. This technology has been applied in daily care, disinfection, and cleaning products for both humans and pets, with expectations to expand into cosmetics, pharmaceuticals, and the food industry in the future, providing more low-carbon alternatives in different fields.

Gold Medal – Light-based devices for disinfection and deodorization

This light-based technology selects a specific wavelength spectrum and is programmed using an asynchronous intermittent (AI) lighting system for disinfection and deodorization purpose. It is widely compatible and can be use seamlessly in conjunction on different devices, offering more mobility compared to most market-available light-disinfection devices. It is also safer, more effective, and quicker in killing microorganisms, including bacteria, spores, viruses, and multidrug-resistant microorganisms compared to traditional UV light disinfection technology. This technology was first integrated into household robot vacuum and multipurpose handheld devices in medical field, including surfaces and items disinfection in hospital wards. Recently, there has been a breakthrough in developing products using the technology for pet skin and fur care, which provide a rapidly elimination of microorganisms residing on pets’ skin and fur. The technology allows pets’ hair and skin disinfection, deodorization and acts as a deterrent for biting insects, promoting skin health and coat luster for pets.

Bronze Medal – Safe and Environmentally Friendly Multilevel Antimicrobial & Pest-Repellent Formulated Products

This product applied the synthesized advanced functional polymer using nano-assembly technology to create multi-functional microcapsules. This microcapsule is designed with antibacterial shells and capable of storing multiple formulas targeting different purposes. In this invention, safe and natural pest repellent formulation is stored inside the microcapsule for controlled release purpose, it therefore achieves a dual-purpose protection, a long-term disinfection of surface microorganisms and insect repellent. It effectively eliminates viruses and microorganisms upon contact while preventing adhesion through its “contact-killing” and “anti-adhesion” properties. Its long-lasting effectiveness, safety, and environmental friendliness, combined with compatibility with everyday products, have garnered significant attention and recognition in the market.

Pioneering Research: Crucial for Proposing Innovative Solutions to Urgent Global Issues

This January, the Hong Kong University of Science and Technology (HKUST) and APEL established a joint laboratory dedicated to developing novel health and environmental innovations and translating research outcomes into practical products. These include highly effective and long-lasting pest repellent against bedbugs that can also inactivate up to 99.9% of highly-infectious viruses, bacteria and hard-to-kill spores. Additionally, artificial organoids have been developed for quantifying pollution’s risks on human health and providing essential data for establishing a health monitoring system in Hong Kong and the Greater Bay Area.

This March, APEL established its presence in Hong Kong Science Park with the opening of the Biomedical Technology Innovation and Translational Commercial Laboratory. The opening event was attended by guests including Ms. Lillian Cheong, Under Secretary for Innovation, Technology and Industry of the Hong Kong Special Administrative Region (HKSAR), and Dr. Grace Lau, Head of Institute for Translational Research of Hong Kong Science and Technology Parks Corporation (HKSTP). Ms. Lillian Cheong highlighted the importance of transforming upstream research and development outcomes into products as a crucial component of developing innovation and technology. APEL has achieved significant success in this area through its accumulated research and development efforts, while the HKSAR Government has been proactively developing the basic research in life and health technology, and promoting the transformation of upstream research and development outcomes into products. With the distinctive advantages of enjoying strong support of the Motherland and being closely connected to the world under the “one country, two systems,” the HKSAR Government will further the transformation of scientific research and development of life and health technology in Hong Kong through such measures as the setting up of life and health technology research institutes and InnoLife Healthtech Hub.

After receiving three awards at the 49th International Exhibition of Inventions Geneva, Dr. David Chung, Chairman of APEL said, “As one of the flagship innovative technology companies in Hong Kong, APEL has experienced rapid development in both national and global markets. This includes our establishment in the Hong Kong Science Park, where we inaugurated the Biomedical Technology Innovation and Translational Commercial Laboratory. Today, we are delighted to receive recognition from international research institutions and achieve remarkable results at the International Exhibition of Inventions Geneva. The success of industry-academia-research collaboration relies on excellent scientific research and further requires involvement from the business community, both of which APEL possesses. In the future, the company will continue to drive the transformation of innovative ideas into market products and solutions by facilitating the commercialization of research and development results, contributing to the growth of the innovation and technology sector in Hong Kong and globally.”

Professor Yeung King Lun from the Department of Chemical and Biological Engineering and Division of Environment and Sustainability at the HKUST stated, “APEL has achieved remarkable success at the International Exhibition of Inventions Geneva. APEL has established a long-term partnership with HKUST, in translating research discoveries into commercial offerings in the areas of health, environment, and sustainability that can have immediate positive impact on lives and well-being of Hong Kong people.”

Successful Development: Innovative Technology Effectively Reduces the Main Components of Sewer Gas

The innovative research and development achievements of Professor Yeung’s research team are extraordinary facilitated by the collaboration between APEL and HKUST. The innovative technology in odors suppression, in particularly hydrogen sulfide, has gained significant attention and benefiting humanity in recent years. Hydrogen sulfide commonly occurs in most drainage systems, including stormwater drains, gully or sewage systems and is one of the main components of sewer gas that lead to respiratory suppression and ultimately death in high concentration. While the gas has a distinct odor at low concentrations, it quickly overwhelms the sense of smell and becomes imperceptible to humans when concentration increase. Recently, there was an industrial accident in Hong Kong where workers, during the maintenance work inside the manhole, fainted and resulting in severe injuries and fatalities due to inhalation of high concentration of hydrogen sulfide.

In light of recent safety issues, APEL aims to actively seek innovative technological developments to create a safer environment and therefore, proactively support and transform the successful research developed. This technology provide a safe environment for manhole workers by effectively reduces hydrogen sulfide concentrations by 99% in the way of killing odor-producing micro-organisms. Throughout the collaboration with various government and private organizations for years, this technology has proven to effectively control odors, bacteria and viruses in drainage and flushing systems, providing a safe and healthy environment for human society. Professor Yeung’s achievement in this technology was recognized with a Silver Medal at the 2022 Geneva International Invention Exhibition, highlighting the importance of technology in ensuring human and environment safety. APEL will continue to collaborate with HKUST to develop more technologies that improve the quality of human life.

Commercialization of High-Quality Scientific Research Results: “The Pet Care Trio” Sets to Debut This Month

Commercialization is an important stage in the success of scientific research. GERMAGIC™ PET, a brand under APEL, will jointly participate in the 11th Premium Pet Supplies Expo 2024 together with Pet Space Group, the largest veterinary group in Hong Kong with veterinary clinics across Hong Kong, Kowloon, and the New Territories, as well as in Singapore from 10 May (Friday) to 12 May (Sunday) at Booth G01, Hall 3, Hong Kong Convention and Exhibition Center in Wan Chai, Hong Kong. At the expo, GERMAGIC™ PET will unveil “The Pet Care Trio,” which includes a deodorizer, an itch relief, and a skin healer. These products utilize GERMAGICTM’s encapsulation technology and are made from natural materials. The long-lasting antibacterial product series not only caters to pets but also effectively eliminates various bacteria and viruses, providing up to 28-day antibacterial protection. Moreover, GERMAGIC™ PET products have received the Quality Pet Protection (QPP) certification. QPP is a scheme led by the IBH Pet Industry Development Standing Committee, supported by Pet Space Group for veterinary professional support, with SGS serving as the scheme secretary for providing testing and certification services. Exclusive offers and free veterinary consultations will also be provided at the expo to comprehensively support and safeguard the health of pets. The new products have already been launched in Hong Kong and Macau this month and are available for sale on HKTVmall, the largest e-commerce platform in Hong Kong, Pricerite, a major home furnishing retailer in Hong Kong, and various pharmacies. Additionally, GERMAGICTM PET plans to enter the Chinese market in mid-June and establish more business partnerships.

APEL has established partnerships with industry leaders in various fields such as biological research, health technology, veterinary clinics, international certification and new materials. By promoting the implementation of scientific research results and transforming innovative ideas into market products and solutions, APEL seizes the opportunity of the continuous and thriving global biotechnology market. According to data from Grandview Research1, the global biotechnology market is expected to reach US$1.55 trillion in 2023 and is projected to continue grow at a compound annual growth rate (CAGR) of 13.96% to reach US$3.88 trillion in the coming years. This shows that the biotechnology industry is ushering in a golden era, and APEL, as a key industry player, will actively promote the development of local and global biomedical technology through the commercialization of scientific research results.

About APEL

Absolute Pure EnviroSci Limited (APEL), an indirect non-wholly owned subsidiary of Yee Hop Holdings Limited, a company listed on the Main Board of the Stock Exchange of Hong Kong Limited (Stock Code: 1662.HK), with a mission to improve the quality of life and living environment, is principally engaged in the business of distribution, research and development of specialty biomedical and biochemical products. APEL looks forward to working with researchers who aspire to help the green industries in Hong Kong grow, contributing together to the city and the Greater Bay Area’s low- carbon transformation and advance towards carbon neutrality, and also give the city impetus to pursue reindustrialization vital to her long-term prosperity.

Note:

1 Data source: https://www.grandviewresearch.com/industry-analysis/biotechnology-market

For media enquiries, please contact:

Avy Yu

Eudice Law

Tel: +852 9500 4443

Tel: +852 9326 1113

Email: avy.yu@ajacapital.com.hk

Email: eudice.law@ajacapital.com.hk

CropLife Asia announces new Office Bearers for 2024

SINGAPORE, May 6, 2024 – (ACN Newswire) – CropLife Asia, the regional voice of the plant science industry, today announced a new lineup for the organization’s Office Bearers within the Board of Directors. Following the CropLife Asia 2024 Annual General Meeting, changes include the installation of Mr. Rahoul Vijay Kumar Sawani as President of CropLife Asia with immediate effect.

Mr. Rahoul Sawani serves as President, Asia Pacific with Corteva Agriscience. Appointed to this position in 2022, Mr. Sawani is responsible for delivering the company’s regional strategy and overseeing the growth of the business in the Asia-Pacific region. Highly experienced in the agricultural sector, Mr. Sawani has held various positions in across the plant science industry in his 18-year career and was previously Vice-President, South Asia with Corteva Agriscience.

The new roster for the CropLife Asia Office Bearers is as follows:

Rahoul Sawani, President, Asia-Pacific, Corteva Agriscience – President
Pramod Thota, President FMC Asia-Pacific, Vice-President, FMC Corporation – Vice-President
Alexander Berkovskiy, Regional Director, AMEA, Syngenta – Treasurer
Simone Barg, Senior Vice President, Agricultural Solutions Asia Pacific, BASF – Secretary

“As climate change intensifies and farmers in Asia face increasing challenges with crop production, plant science plays an important role in ensuring a robust, resilient and sustainable food system for the region. We’re grateful to have experienced and strong leaders comprising our CropLife Asia Board of Directors at such a consequential time for our region,” said Dr. Siang Hee Tan, Executive Director of CropLife Asia.

About CropLife Asia

CropLife Asia is a non-profit society and the regional organization of CropLife International, the voice of the global plant science industry. We advocate a safe, secure food supply, and our vision is food security enabled by innovative agriculture. CropLife Asia supports the work of 15 member associations across the continent and is led by six member companies at the forefront of crop protection, seeds and/or biotechnology research and development. For more information, visit us at www.croplifeasia.org.

For more information please contact:
Duke Hipp
Director, Public Affairs & Strategic Partnerships
CropLife Asia
Tel: (65) 6221 1615
duke.hipp@croplifeasia.org

JBM Healthcare Issues Positive Profit Alert

HONG KONG, May 5, 2024 – (ACN Newswire) – JBM (Healthcare) Limited (“JBM Healthcare” or the “Company”; Stock Code: 2161, together with its subsidiaries, the “Group”), a leading branded healthcare products marketer and distributor in Hong Kong, has announced a positive profit alert. Based on a preliminary review of the unaudited consolidated management accounts of the Group for the financial year ended 31 March 2024 and the information currently available to the board of directors of the Company, the Group is expected to record an increase in the consolidated profit attributable to shareholders for the year ended 31 March 2024 (“Consolidated Profit”) by not less than 120% as compared to that for the same period last year.

The significant increase in Consolidated Profit stems from a combined effect of the improvement in overall retail market sentiment due to the gradual recovery of tourist travel to Hong Kong, alongside the effective execution of advertising and marketing strategies for our key brands under the proprietary medicine category, notably Po Chai Pills and Ho Chai Kung. This promising performance underscores our disciplined execution of growth strategies along the offline and online platforms, with positive progress being made on the cross-border e-commerce trade.

JBM Healthcare has a diversified portfolio spanning branded medicines, proprietary Chinese medicines, and health and wellness products. The Group continues to make progress on its strategic priorities, including expanding e-commerce platforms locally and cross-border, exploring opportunities in traditional Chinese medicines for Hong Kong and the Greater Bay Area, adapting its product mix to consumer trends, and enhancing commercial execution.

For details, please refer to the announcement on HKEX.

About JBM (Healthcare) Limited (Stock Code: 2161)

JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and certain other countries. The Group is a unique field player with marketing expertise and a drug heritage that prioritises product efficacy and quality to meet consumers’ healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex, BITE-X, Mederma for Kids, Tong Tai Chung Woodlok Oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling Oil and Konsodona Medicated Oil. JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hk

UVify Sets New Guinness World Record With 5,293 IFO Drones in Spectacular Aerial Display

INCHEON, SOUTH KOREA, May 4, 2024 – (ACN Newswire) – UVify, the leader in swarm drone innovation, has achieved a new Guinness World Record for the most unmanned aerial vehicles (UAVs) airborne simultaneously. This historic event took place in Songdo, Korea, where UVify orchestrated a breathtaking display of 5,293 IFO drones that lit up the night sky, setting a new global standard for drone technology and performance.

Guinness World Record for the most unmanned aerial vehicles (UAVs) airborne simultaneously
UVify Sets New Guinness World Record with 5,293 IFO Drones in Spectacular Aerial Display

The fleet of IFO drones created intricate patterns and vibrant visuals above the awe-struck crowd, showcasing UVify’s advanced programming and drone control technology. The record-breaking feat exceeded the previous record and demonstrated the immense capabilities of the IFO drones, designed specifically for high-impact entertainment and precision flying.

Hyon Lim, CEO of UVify, expressed his enthusiasm for the achievement, stating, “This event was not just about setting a world record; it was a demonstration of the innovative spirit and the relentless pursuit of excellence that drive our team at UVify. We are proud to lead the way in drone technology and to showcase our capabilities on the world stage here in Songdo.”

Robert Cheek, COO of UVify, added, “Today’s achievement is a milestone not only for our company but also for the broader potential of UAV technology. The flawless execution of such a large-scale drone show underlines our commitment to excellence and our ability to push the boundaries of what is possible in synchronized drone performance.”

The record-setting event was meticulously planned in cooperation with local authorities and air traffic control to ensure safety and compliance with all regulatory standards. Each drone performed with precision, reflecting UVify’s commitment to quality and safety in all of its technological endeavors.

The achievement was officially recognized and verified by a Guinness World Records adjudicator on-site, who commended UVify for their impeccable execution and innovative approach to aerial entertainment. This event not only places UVify at the forefront of the UAV industry but also sets the stage for future advancements in drone technology.

Contact Information
Robert Cheek
Chief Operating Officer
robert.cheek@uvify.com

Hyon Lim
CEO
lim@uvify.com

SOURCE: UVify Inc.

View the original press release on newswire.com.

Singapore’s top general insurer debuts trading on Asia’s leading digital exchange, AltaX

The inaugural trades are part of the Income Insurance Share Liquidity Program launched in January 2024 by Alta and PhillipCapital for Income Insurance shareholders
The listing of shares for Income Insurance on AltaX, whose Net Asset Value is S$3.2 billion[1](US$2.35 billion), marks the largest listing of a non-listed company on a private market digital securities exchange

SINGAPORE, May 3, 2024 – (ACN Newswire) – Alta, a leading private markets digital securities exchange in Asia and Phillip Securities Pte. Ltd (PSPL), the largest retail broker in Singapore, today announced the inaugural trade for the first tranche of shares from Income Insurance Limited (Income Insurance) shareholders.

The trade was part of the Income Insurance Share Liquidity Program launched by Alta, through Alta’s exchange arm AltaX, and PSPL in January this year. The program provides a liquidity solution to almost 16,000 shareholders holding shares valued as much as S$840 million (US$619 million).

Additional windows for Income Insurance shareholders to sell their shares to PSPL will follow this first window, later this year.

This liquidity program enables all shareholders of Income Insurance to reach out to PSPL to sell their shares. PSPL would then sell these shares on AltaX where they then become available to investors for trading.

Investors will be able to trade these shares seamlessly on AltaX, taking advantage of the digital exchange’s market participants, which includes an active global community of traders and market makers.

Kelvin Lee, Chief Executive Officer, Alta said, “Today’s inaugural trade for Income Insurance, marks a significant milestone in the evolution of private market liquidity. Shareholders, who have predominantly held Income Insurance shares for decades, now have a means to monetize their investments—a possibility that simply did not exist prior to the launch of this liquidity program.”

“Platforms such as Alta are reshaping the trajectory of private companies, providing them with the means to prolong their private status while accessing a diverse array of capital sources. Since the program’s inception in January, we’ve witnessed an overwhelming influx of inquiries from major unlisted entities worldwide. This surge underscores the profound impact of our technology-driven exchange, not only in fostering value creation but also in promoting financial inclusivity across the global economy,” added Kelvin.

Luke Lim, Managing Director, Phillip Securities added, “We are proud to pioneer the Income Insurance Share Liquidity Program in partnership with Alta. This collaboration not only underscores our dedication to delivering value to our clients but also reinforces our position as a leader in driving positive change in the industry. Through this partnership, Phillip Securities has enabled Income Insurance shareholders to seamlessly monetise their investments while AltaX provides institutional and accredited investors with unprecedented access to Income Insurance shares, along with a host of other alternative assets. Together with Alta, we’re shaping the future of trading alternative investments.”

Since inception, Alta has aimed to solve the issue of private market illiquidity by providing a secure exchange for buyers and sellers to trade in private shares. Besides Income Insurance, shares or funds of companies like SpaceX, Open AI, Epic Games, Discord, Bytedance, Hamilton Lane etc. have listed and traded on AltaX.

To date, Alta completed transactions worth US$700 million and enabled investments into over 100 unique companies. Trading volumes on Alta have shown a significant year on year growth, with an increase of over 300 per cent in order volume, from US$32 billion in 2022 to US$141 billion in 2023.

[1] Net Asset Value as of 2022

About Alta

As the leading licensed digital securities exchange for alternative investments in Asia, we are building critical capital market infrastructure backed by the most active securities brokerages and bookrunners on the Singapore Exchange – Phillip Securities, PrimePartners and Nomura Holdings (Japan).

Empowering Private Markets: Through our Digital Exchange, we enable the tokenization and digital custody of alternative assets. This end-to-end solution simplifies and expedites the trading of smaller asset blocks, ultimately facilitating access and liquidity in private markets. We believe that access to capital markets are pivotal in all economies, we recognize that our role in building this critical infrastructure goes beyond facilitating trades; it paves the way for entrepreneurship, job creation, financial inclusion, and economic resilience, fostering a brighter future for emerging markets and economies.

Innovative Financial Ecosystem: Our journey has seen us transition from securities trading and distribution of comprehensive products, including equities, private credit, funds, and asset-backed securities representing real world assets like whiskies, wines, to include fund management and digital custody.

Visit us on https://alta.exchange/

About PhillipCapital

Since inception in 1975, PhillipCapital has grown into an integrated Asian financial house with a global presence, offering a full range of quality and innovative services to retail and high net worth individuals, family offices, as well as corporate and institutional customers.

Today, PhillipCapital headquartered in Singapore, operates in the financial hubs of 15 countries, including offices in Australia, Cambodia, China (and Hong Kong SAR), India, Indonesia, Japan, Malaysia, Singapore, Spain, Thailand, Turkey, UK, UAE, USA and Vietnam, serving over 1 Million clients with Assets Under Management of total more than USD 35 Billion.

NOTE TO EDITORS
For media inquiries, please contact:
PRecious Communications for Alta
alta@preciouscomms.com